STERIS (STE) Stock

I am changing my rating for STERIS to 'Buy' with a target price of $240 per share because of the recent drop in stock price and promising growth potential. The company showed a 7.2% increase in organic revenue and a 5.4% rise in adjusted earnings per share, particularly excelling in the Applied Sterilization Technologies area. Even with high interest rates, I expect the biotech sector to slowly recover, which should lead to strong double-digit revenue growth for STERIS' AST division.

On Wednesday, Steris, a company that makes medical equipment, exceeded profit expectations for the second quarter. This was due to ongoing demand for non-urgent medical procedures, which increased sales of its surgical and examination tools.

DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has released its financial results for the second quarter of fiscal 2025, which ended on September 30, 2024. The company reported a 7% rise in total revenue from continuing operations, reaching $1.3 billion, up from $1.2 billion in the same quarter of fiscal 2024. Additionally, the constant currency organic revenue from continuing operations also grew by 7%.

In addition to looking at analysts' estimates for Steris's (STE) revenue and earnings, it's important to assess forecasts for some of its main metrics. This will help us understand how the company may have performed in the quarter that ended in September 2024.

DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will pay a quarterly interim dividend of $0.57 per share. This dividend will be paid on December 19, 2024, to shareholders who are on record as of the end of business on November 19, 2024.

Steris (STE) has the right mix of factors that could lead to a strong earnings report soon. Be ready for the important expectations.

DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) has announced that it will hold a conference call to go over its financial results for the second quarter of fiscal 2025 at 9:00 a.m. ET on November 7, 2024. You can listen to the call live at www.steris-ir.com or by calling 1-833-535-2199 in the U.S. or 1-412-902-6776 internationally and requesting to join the STERIS plc conference call.

Steris (STE) shared its earnings report 30 days ago. What can we expect for the stock moving forward?

STE's positive outlook in the healthcare sector is promising for investors. This suggests that there may be good opportunities for growth and returns. Overall, it looks like a good time for investment in this area.